The start of 2026 has seen a flurry of activity across the US insurance and industrial sectors, with a host of previously announced deals crossing the finish line.
Baldwin merges with CAC Group
The Baldwin Group announced it has completed its merger with CAC Group, a nationally recognized specialty and middle-market brokerage.
The transaction strengthens Baldwin’s capabilities across commercial and specialty lines while adding CAC’s established middle-market expertise to its platform. The merger is expected to enhance Baldwin’s ability to deliver tailored insurance solutions to a broad client base, combining resources, distribution networks and advisory services.
SageSure expands in Florida's mass affluent homeowners market
SageSure has completed its acquisition of Gemini Financial Holdings Corporation and its Olympus subsidiaries in Florida.
This acquisition allows SageSure to expand its footprint in the mass affluent homeowners' segment and strengthens its catastrophe-exposed market capabilities.
With approximately 130,000 in-force policies, $700 million in gross written premium, and a network of 1,500 independent agents in Florida, SageSure said it is now positioned to leverage Gemini’s local expertise and Olympus’ elite repair program to further differentiate its offerings.
Elephant Insurance joins J.C. Flowers
In the auto insurance sector, Admiral Group plc has completed the sale of its US motor insurance business, including Elephant Insurance Company, to J.C. Flowers & Co., a private investment firm focused on financial services.
Elephant’s platform emphasizes simplicity and affordability for US motorists, and the acquisition is expected to provide additional capital and strategic support to scale the business nationally. The deal also underscores investor interest in US personal lines insurance, particularly digital-first and customer-centric platforms that allow for flexible and customized coverage.
Berkshire Hathaway acquires OxyChem
Berkshire Hathaway has completed the acquisition of OxyChem from Occidental for $9.7 billion, subject to customary post-closing purchase price adjustments.
OxyChem, headquartered in Dallas, Texas, is a leading producer of essential chemicals, including polyvinyl chloride, chlor-alkali, chlorinated organic chemicals, and calcium chloride, with operations across the US, Canada, and Latin America. OxyChem’s products are critical to industries such as water treatment, pharmaceuticals, healthcare, manufacturing, automotive, personal hygiene, and construction.
Wade Alleman will continue to serve as OxyChem president and CEO, ensuring continuity in operations and strategy.
